1
Ribosome recruitment onto the HIV-1 unspliced mRNA has been shown to occur through cap-2 dependent and cap-independent mechanisms (1-3). Initial studies showed that the highly 3 structured 5´-untranslated region (5´-UTR) present within the full-length unspliced mRNA was 4 inhibitory for translation in cell-free translation systems suggesting that cap-dependent ribosome 5 scanning was not an efficient mechanism of translation initiation operating in HIV-1 transcripts 6 (4-6). In agreement with this idea, several groups have reported that the 5´-UTR of the HIV-1 7 unspliced mRNA harbors a cell cycle-dependent internal ribosome entry site (7) (8) (9) (10) (11) . However, 8 more recent reports including ours have shown that cap-dependent ribosome scanning operates 9 on the unspliced mRNA in a mechanism supported by the host DEAD-box RNA helicase DDX3 10 but independent of the cap-binding protein eIF4E (12) (13) (14) (15) (16) . In this sense, HIV-1 unspliced mRNA 11 translation was also proposed to occur in a nuclear cap-binding complex (CBC)-dependent 12 fashion during the virally induced arrest of the cell cycle (17) . Consistent with these 13 observations, we have recently reported that the CBC subunit CBP80 (NCBP1) promotes nuclear 14 export and translation of the HIV-1 unspliced mRNA by supporting the functions of the viral 15 protein Rev on these processes (18) . 16
The CBC is recruited onto the nascent transcript early during transcription and has been involved 17 in every step of mRNA metabolism from transcription to splicing, nuclear export, translation and 18 decay (19) . Two different CBCs have been described so far in mammalian cells, the canonical 19 CBC composed by CBP20 (NCBP2) and CBP80 and a recently described CBC in which CBP80 20 interacts with the newly discovered cap-binding protein NCBP3 (20, 21) . CBC-dependent 21 translation has mostly been associated to the mRNA quality control mechanism known as 22 nonsense-mediated mRNA decay (NMD), which triggers the degradation of mRNA harboring 23 premature stops codons (22) (23) (24) . 24
Translation initiation driven by the CBC relies on the CBP20/80 translation initiation factor 25 (CTIF), which binds to the CBP80 subunit and interacts with eIF3 to promote 40S small 26 ribosomal subunit recruitment (25, 26) . CTIF also recruits the DEAD-box RNA helicase 27 eIF4AIII, which drives the unwinding of RNA structures on the 5´-UTR of mRNA translated 28 through a CBC-dependent mechanism (27). More recently, it was shown that CTIF couples 29 translation with autophagy by driving misfolded poplypetides to the aggresomes (28). Here, we 30 report that CTIF is a potent inhibitor of Gag synthesis that blocks unspliced mRNA translation. 31 antibody diluted to 1/1000 (Catalog number 3537), a rabbit anti-CTIF antibody (ThermoFisher 1 Scientific) diluted to 1/250, a mouse anti-GAPDH antibody (Santa Cruz Biotechnologies) diluted 2 to 1/5000, a rabbit anti-MLV CA (kindly provided by Dr. Gloria Arriagada, UNAB, Chile) 3 diluted 1/1000, a mouse anti-F protein of HRSV (Santa Cruz Biotechnologies) diluted 1/500, or 4 mouse anti-puromycin antibody (Milipore, clone 12D10) and anti-actin antibody (Santa Cruz 5 Biotechnologies) diluted 1/750. Upon incubation with the corresponding HRP-conjugated 6 secondary antibody (Jackson ImmunoResearch) diluted to 1/5000. Membranes were revealed 7 with the Pierce® ECL substrate or SuperSignal TM West femto (Thermo Scientific) using a Mini 8 HD9 Western blot Imaging System (UVItec). 9
10

CTIF knock down, stable cell line generation, proviral transfection and recovery assay 11
Lentiviral particles carrying an anti-CTIF shRNA were produced in HEK293 cells by 12 transfecting a commercially available pLKO.1 vector containing the shRNA sequence targeting 13 the 3´-UTR of the CTIF mRNA (Sigma-Aldrich), pVSVg and psPax2. Supernatants were 14 collected at 48 hours post transfection, cleared through a 0.22 µm filter and used to transduce 15
HeLa cells for 24 hours. The medium containing the lentiviral particles was replaced by fresh 16 DMEM and cells were grown for additional 48 hours. Finally, cells were treated with puromycin 17 (10 µg/mL) for 10 days at 37˚C and 5% CO 2 . CTIF knockdown was evaluated by Western blot 18 as mentioned above. Lentiviral particles carrying a scramble shRNA were used as a control. The 19 sequences of CTIF and scramble shRNAs are in Supplementary Table 1 . 20
Control and CTIF knockdown cells were transfected with pNL4.3R together with pcDNA-21 d2EGFP or pcDNA3-Flag CTIF, and Renilla luciferase activity was determinated as mentioned 22 above. 23
24
Pseudotyped virus production and infection assays 25
HEK293T cells were co-transfected with the pNL4.3-DEnv provirus and pVSVg and cell 26 supernatants were collected at 72 hour post-transfection, cleared through a 0.22 µm filter and 27 used to infect Jurkat cells by using 1 volume virus stocks per volume of cells. Infected cells were 28 recovered at 8, 12, 20, 24, 48, 72, 96 hours post-infection and washed with 300 µl of PBS and 29 pelleted at 500 x g for 5 min at 4 ºC. Cells were resuspended in 100 µl of ice cooled lysis Buffer 30 I (150 mM sodium chloride, 1.0% NP-40, 0.5% sodium deoxycholate, 50 mM Tris-HCl, pH 7.5 31 and protease inhibitor [Roche]), vortexed for 5 seconds, incubated for 30 min at 4˚C under 1 agitation and centrifuged at 12,000 rpm for 20 min at 4˚C. The supernatant containing the whole 2 cellular lysate was recovered and 30 µg of total protein were used for Western blot analysis. 3
For hRSV production HEp-2 cells were infected with 500 µl of the virus and supernantants were 4 recovered when an 80% of cytopathic effect was observed. Supernatants were cleared by 5 centrifugation and stored at -80˚C. For quantification of hRSV we perform a TCID 50 in the 6 MA104 cell line as previously described (31). 7 8 Surface Sensing of Translation (SUnSET) assay 9
Global proteins synthesis under control or CTIF overexpression was analyzed using the 10 puromycin incorporation into new peptide synthesis as previously described (32). Briefly, HeLa 11 cells were transfected with pcDNA-d2EGFP or pcDNA3-Flag-CTIF and treated with 10 µg/ml 12 of puromicine for 10 min at 37˚C and 5% CO 2 at 24 hpt. Cells were washed with PBS twice and 13 lysed with lysis Buffer II (10 mM Tris-HCl pH 7.5, 100 mM NaCl, 0.5% NP-40, 1 mM EDTA 14 and EDTA-free protease inhibitors cocktail [Roche]). As a control of protein synthesis inhibition, 15
we treated HeLa cells with 0.5 mM of arsenite (Sigma-Aldrich) for 45 min prior to puromycin 16 treatment. 20 µg of total proteins were loading in a SDS gel for Western blot analysis. 17
18
RNA extraction and RT-qPCR 19
Cytoplasmic RNA extraction and RT-qPCR from cytoplasmic RNA were performed exactly as 20 we have previously described (18, 29) . The GAPDH housekeeping gene was amplified in parallel 21 to serve as a control reference. Relative copy numbers of HIV-1 unspliced mRNA were 22 compared to GAPDH using x −∆Ct (where x correspond to the experimentally calculated 23 amplification efficiency of each primer couple). Sequences of the primers used and the 24 experimentally calculated amplification efficiency of the primers are presented in Supplementary 25 Table 2 . 26 27 RNA fluorescent in situ hybridization, immunofluorescence and confocal microscopy 28 RNA FISH and immunofluorescence analyses were performed exactly as we have recently 29 reported but using an anti-Flag (Sigma-Aldrich) instead of an anti-HA primary antibody (18). 30 31 Proximity ligation assay (PLA) and in situ hybridization coupled to PLA (ISH-PLA) 1 PLA and ISH-PLA were carried out using mouse anti-digoxin (Roche) and rabbit anti-Flag 2 (Sigma-Aldrich), the DUOLINK II In Situ kit (Sigma-Aldrich) and PLA probe anti-mouse minus 3 and PLA probe anti-rabbit plus (Sigma-Aldrich) exactly as we have recently described (18). 4 5 RESULTS 6
CTIF regulates HIV-1 Gag synthesis during viral replication 7
We have recently reported that CBP80 promotes Gag synthesis from the unspliced mRNA in 8 association with the viral protein Rev (18). Since CTIF bridges CBP80 and the 40S ribosomal 9 subunit by interacting with eIF3g during CBC-dependent translation, we sought whether CTIF 10 was involved in gene expression from the HIV-1 unspliced mRNA. We first analyzed the 11 expression of the endogenous protein in HIV-1-infected T-cells and observed that the presence 12 of HIV-1 induced an increase in the levels of CTIF from 8 to 24 hour post-infection to then 13 decrease at later time points ( Fig. 1A , upper panel). We consistently observed that the drop in the 14 levels of CTIF was correlated with the accumulation of the Gag polyprotein ( Figure 1A , lower 15 panel), which led us to speculate that increased levels of CTIF are not required for the synthesis 16 of Gag. Consistent with such hypothesis, overexpression of Flag-tagged CTIF in HeLa cells 17 resulted in a strong inhibition of HIV-1 Gag synthesis from the pNL4.3R reporter provirus (Fig. 18 1B) . It should be mentioned that Flag-CTIF overexpression had no impact on gene expression 19 from a reporter vector, on global protein synthesis or in other viral proteins such as Vif 20 suggesting a specific effect on HIV-1 Gag synthesis (Supplementary Figs. 1A, 1B and 1C) . In 21 agreement with a negative effect of CTIF on Gag synthesis, we observed that even a mild 22 reduction of the endogenous levels of CTIF resulted in enhanced levels of Gag synthesis, which 23 were further reduced when Flag-CTIF was ectopically expressed (Fig. 1C) . 24
Taken together these results indicate that CTIF is a negative regulator of Gag synthesis during 25
HIV-1 replication. 26
27
CTIF inhibits Gag synthesis in a Rev-dependent manner 28
CTIF is a CBC-dependent translation initiation factor that is recruited to the mRNP upon nuclear 29 export and was shown to play a scaffold role during the pioneer round of translation (25, 26) . 30
Thus, in order to identify the step at which CTIF was interfering with Gag synthesis, we 31 analyzed the impact of CTIF overexpression on the cytoplasmic levels of the unspliced mRNA. 1
Despite we observed a strong inhibition of Gag synthesis under ectopic expression of CTIF, the 2 cytoplasmic levels of the unspliced mRNA levels were minimally affected. However, this 3 reduction in the cytoplasmic unspliced mRNA does not explain the strong decrease in Gag 4
indicating that CTIF might exert its effects on translation ( Fig. 2A) . 5
Since the viral protein Rev is the major post-transcriptional regulator of the unspliced mRNA by 6 allowing the efficient nuclear export and translation of the viral transcript, we then sought to 7 determine whether Rev was involved in the inhibition of Gag expression mediated by CTIF. 8
Thus, we analyzed the impact of Flag-CTIF expression on Gag synthesis in the presence or 9 absence of Rev. Despite our ∆Rev provirus produced lower amounts of Gag when compared to 10 the wild type provirus (data not shown), we observed that CTIF was unable to exert the strong 11 inhibition of Gag synthesis in the absence of Rev, suggesting that CTIF may at least target the 12 function of Rev during unspliced mRNA translation ( Fig. 2B ). As such, our proximity ligation 13 assay revealed that Flag-Rev interacts with endogenous CTIF ( Fig. 2C and Supplementary Fig.  14 
2). 15
Taking together, these data suggest that CTIF interacts with Rev and targets the function of the 16 viral protein during translation of the unspliced mRNA. 17
18
CTIF inhibits Gag synthesis through its N-terminal CBP80-binding domain 19
CTIF was shown to contain two major domains, the N-terminal region (CTIF 1-305) that 20 contains the CBP80-binding domain and C-terminal region (CTIF 306-598), which harbors a 21 MIF4G domain (25) (Fig. 3A) . Thus, in order to determine whether the inhibitory activity of 22 CTIF was exerted by one of these domains, we evaluated their impact on Gag synthesis from the 23 pNL4.3R reporter provirus ( Fig. 3B ). We observed that ectopic expression of the N-terminal 24 domain alone was able to inhibit the synthesis of Gag in a similar level compared with the full-25 length protein. The C-terminal domain was unable to interfere with Gag synthesis indicating that 26 the N-terminal domain contains the inhibitory activity of CTIF. Similar results were obtained by 27
Western blot using the pNL4.3 provirus and an anti-Cap24 antibody indicating that these effects 28 are not exerted on the Renilla luciferase activity ( Supplementary Fig. 3A ). 29
Consistent with the N-terminal domain as the responsible of the inhibitory effect of CTIF on Gag 30 synthesis, we observed that this domain, but not the C-terminal domain, interacts with EGFP-31
Rev similar to the wild type protein (Fig. 3B) . Interestingly, we observed that the Rev-CTIF 1 interaction mainly occurs in the cytoplasm consistent with CTIF targeting the cytoplasmic 2 functions of Rev on translation of the unspliced mRNA (see below). 3
We then used in situ hybridization coupled to the proximity ligation assay (ISH-PLA) in order to 4 evaluate whether full-length CTIF and its isolated domains were recruited to the unspliced 5 mRNA ribonucleoprotein complex during viral replication. We observed that both full-length 6 CTIF and the N-terminal domain form complexes with the viral transcript ( Fig. 3C ). Consistent 7 with its inability to interact with Rev and to interfere with Gag synthesis, we observed that the C-8
terminal domain of CTIF is not recruited to the unspliced mRNA. It should be mentioned that 9 neither full-length CTIF nor the isolated domains altered the subcellular localization of the 10 unspliced mRNA as judged by RNA FISH and confocal microscopy analyses (Supplementary 11 Fig. 3B ). 12
Taking together, these data suggest that CTIF interacts with Rev through its N-terminal domain 13 and this interaction allows the recruitment of CTIF to the unspliced mRNA leading to the 14 inhibition in Gag synthesis. 15
16
CTIF affects the subcellular localization of Rev and its interaction with CBP80 17
From data presented above, it seems that CTIF and Rev mainly interacts in the cytoplasm despite 18 most of the viral protein is normally found in the cell nucleus concentrated at the nucleolus. 19
Thus, we sought to determine whether CTIF has an impact on the subcellular localization of 20 EGFP-Rev. As expected, EGFP-Rev signal was mainly present in the nucleus/nucleolus of the 21 cells under control conditions. However, we observed a significant increase of the cytoplasmic 22 signal of EGFP-Rev when either full-length CTIF or the N-terminal domain were expressed 23 together with the viral protein ( Fig. 4A) . Quantification of the subcellular localization of EGFP-24
Rev indicates that under control conditions near of the 90% of the cells exhibit an exclusive 25 nuclear localization of EGFP-Rev (Fig. 4B ). In contrast, we observed that 70-80% of the cells 26 We recently reported that Rev associates with CBP80 to promote nuclear export and translation 1 of the unspliced mRNA. Thus, we wanted to investigate whether the inhibitory activity of full-2 length CTIF was related with this interaction. Quantification of our PLA experiments showed 3 that expression of CTIF strongly interferes with the interaction between Rev and CBP80 ( Fig. 4C  4 and Supplementary Fig. 4) . 5
Taking together, these data suggest that CTIF induces a cytoplasmic retention of Rev and 6 interferes with the association between the viral protein and CBP80. This lack of interaction 7 between Rev and CBP80 in the presence of CTIF may result in the inhibition of Gag synthesis. 8 9
CTIF-mediated restriction is conserved in human lentiviruses 10
We finally wanted to determine whether the negative effect of CTIF was exclusive for Rev-11 containing human lentiviruses or was conserved in simple retroviruses or other RNA viruses. For 12 this, we first evaluated the effect of CTIF expression on an HIV-2 reporter provirus. We 13 observed that similar to HIV-1, Gag synthesis from the HIV-2 unspliced mRNA was also 14 inhibited by CTIF (Fig. 5A ). This result correlate with the presence of the regulatory protein Rev 15 in both complex human lentiviruses. Thus, in order to corroborate whether the presence of Rev is 16 determinant for the inhibition mediated by CTIF, we evaluated the effect of this cellular protein 17 on Gag synthesis from the simple retrovirus Murine Leukemia Virus (MLV), which do not 18 express a Rev-like regulatory protein and also on human Respiratory Syncytial Virus (hRSV), 19
which is a non-related negative stranded RNA virus (Figs. 5B and 5C). We analyzed the effects 20 of CTIF overexpression on the synthesis of Gag from MLV and the fusion protein (F-protein) 21 from hRSV but none of these viruses was affected, indicating that CTIF is not a pan-antiviral 22 protein but rather selectively targets human lentiviruses expressing the viral protein Rev. 23
24
DISCUSSION 25
From an RNA biology point of view, Gag synthesis from the HIV-1 unspliced mRNA should not 26 be as efficient as it is. This is because this viral transcript possesses several features known to be 27 incompatible with efficient nuclear export and translation in mammalian cells. First, it contains 28 functional splice donors and acceptors sites and thus, it needs to subvert the cellular splicing 29 machinery in order to accumulate in the nucleus of infected cells. Second, the lack of intron 30 removal avoids the splicing-dependent recruitment of nuclear host factors and thus, the unspliced 31 mRNA is not assembled into a canonical mRNP that exits the nucleus associated to NXF1 and is 1 directed to the translational machinery in the cytoplasm. Third, it harbors a highly structured 5´-2 UTR expected to interfere with the cap-dependent ribosomal scanning mechanism of translation 3 initiation. Despite all these functional constraints, the HIV-1 unspliced mRNA reaches the 4 cytoplasm efficiently and is highly specialized in ribosome recruitment producing huge amounts 5 of Gag protein during viral replication. The viral protein Rev orchestrates the post-transcriptional 6 regulation of the unspliced mRNA by acting as a multifunctional bridge between host factors and 7 the viral transcript. By binding the Rev response element (RRE) present at the 3´-UTR of the 8 unspliced mRNA through an RNA binding domain and the host karyopherin CRM1 through its 9 nuclear export signal (NES), Rev ensures the cytoplasmic accumulation of the viral mRNA. Rev 10 has also been involved in ribosome recruitment of the unspliced mRNA although the 11 mechanisms at play are poorly understood. Recent work including ours reported that Rev 12 interacts with the CBC subunit CBP80. In our study, we demonstrated that CBP80 cooperates 13
with Rev during nuclear export and translation of the unspliced mRNA. We also showed that the 14 unspliced mRNA preferentially associates with CBP80 and that Rev promotes this association. 15
Since we reported that Rev favored the association of a complex also containing the DEAD-box 16
RNA helicase eIF4AI but not other translation initiation factors such as eIF4GI or eIF3g, we 17 decided to further investigate the composition of this unusual viral mRNP. We focused on CTIF 18 since it is the translation initiation factor that scaffolds the CBC-bound mRNP and the 40S 19 ribosomal subunit through interactions with CBP80 and eIF3g. However and to most of our 20 surprise, we observed that CTIF rather inhibits HIV-1 replication by blocking Gag synthesis. An 21 interesting point of our observations is that CTIF levels increased at early hours post-infection to 22 then decrease when Gag started to accumulate suggesting that CTIF would not be necessary or 23 deleterious for the synthesis of this viral protein. Since CTIF seems not to be an interferon 24 stimulated gene (33), we believe that endogenous CTIF levels must be increased by the virus in 25 order to promote the accumulation of early viral gene products such as Tat and Rev, which are 26 expressed from multiply spliced transcripts and follows a canonical gene expression pathway. 27
Then, HIV-1 may induce the decrease in the levels of CTIF in order to accumulate the structural 28 protein Gag. In support of this, we showed that low level of CTIF promoted the accumulation of 29
Gag, while high levels of CTIF were inhibitory for Gag synthesis. Indeed, CTIF binds Rev 30 through its N-terminal domain inducing the cytoplasmic accumulation of the viral protein and 1 impeding the assembly or inducing the disassembly of the Rev-CBP80 complex (Fig. 6) . 2
Considering the different origins of HIV-1 and HIV-2, the specific inhibition of Gag synthesis 3 observed in both human lentiviruses and the high conservation of CTIF between human and non-4 human primates (data not shown), it is tempting to speculate that the inhibition of replication 5 mediated by CTIF must be conserved at least in primate lentiviruses. 6
The small molecule ABX464 was shown to interfere with HIV-1 replication by targeting the 7 function of Rev and CBP80 and is currently in a phase II clinical trial. This information together 8 with our results confirm the critical relevance of the Rev-CBP80 complex on HIV-1 replication 9 and highlights the usefulness of this interaction as a reliable target for the development of novel 10 antiretroviral therapies aimed to interfere with viral gene expression from the unspliced mRNA. 
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Echeverria 12, 20, 24, 48, 72 and 96 hours post-infection were used to detect Gag (and its processing 25 intermediates) and CTIF by Western blot. GAPDH was used as loading control. Band intensity 26 for CTIF and Gag (pr55) from three independent experiments were quantified, normalized to 27 GAPDH and plotted (n = 3, +/-SEM). 28 B) HeLa cells were transfected with 1 µg of pcDNA-d2EGFP (Control) or pcDNA3-Flag-CTIF 29 together with 0.3 µg of pNL4.3R as described in materials and methods and Renilla activity was 30 determined 24 hpt. Results were normalized to the control (arbitrary set to 100%) and correspond 31 to the mean +/-SD of three independent experiments (**P < 0.01, t-test). In parallel, cells 32 extracts were used to detect Flag-CTIF by Western blot for expression control. Actin were used 33 as a loading control. 34 C) Scramble and CTIF knockdown HeLa cells were transfected with 1 µg of pcDNA-d2EGFP 35 (used as a control) or pcDNA3-Flag-CTIF together with 0.3 µg of pNL4.3R as described in 36 materials and methods. Renilla luciferase activity was determined at 24 hpt. Results were 1 normalized to the control (arbitrary set to 100%) and correspond to the mean +/-SD of three 2 independent experiments (*P < 0.05; **P < 0.01 and ****P < 0.0001, t-test). Extracts from HeLa 3 Scramble and CTIF knockdown cells were used to verify CTIF knockdown by Western blot. 4
GAPDH was used as a loading control. hpt. Results were normalized to the control (arbitrary set to 100%) and correspond to the mean 11 +/-SD of three independent experiments (**P < 0.01, t-test). 12 B) HeLa cells were transfected with 1 µg of pCDNA-d2EGFP (used as a control) or pCDNA-13
Flag-CTIF together with 0,3 µg of pNL4.3R or pNL4.3R-DRev and Renilla luciferase activity 14 was determined at 24 hpt. Results were normalized to the control (arbitrary set to 100%) and 15 correspond to the mean +/-SD of three independent experiments (*P < 0.05; **P < 0.01, t-test). 16
Extracts from HeLa from different conditions were used to verify CTIF overexpression by 17
Western blot. Actin were used as loading control. 18 C) HeLa cells transfected with 1 µg pEGFP-Rev were subjected to the proximity ligation assay 19 using a rabbit anti-CTIF antibody (rabbit) and a mouse anti-GFP antibody and the Duolink ® in 20 situ kit as described in materials and methods. Mock corresponds to untransfected cells. with 1 µg of pCDNA-d2EGFP (used as a control), pCDNA3-Flag-CTIF, pCDNA3-Flag-CTIF(1-28 305) or pCDNA-Flag-CTIF(306-598) together with 0,3 µg of pNL4.3R as described in materials 29 and methods. Renilla activity was determined at 24 hpt. Results were normalized to the control 30 (arbitrary set to 100%) and correspond to the mean +/-SD of three independent experiments 31 (**P < 0.01; NS= non-significant, t-test). Right panel: In parallel, cells extracts were used to 1 detect Flag-CTIF by Western blot for expression control. Actin were used as a loading control. 2 B) HeLa cells transfected with 1 µg of pEGFP-Rev together with 1 µg of pCDNA3-Flag-CTIF, 3 pCDNA-Flag-CTIF(1-305) or pCDNA-Flag-CTIF(306-598) were subjected to the proximity 4 ligation assay using a rabbit anti-Flag antibody (rabbit) and a mouse anti-GFP antibody and the 5 DuolinkⓇ in situ kit. Mock corresponds to untransfected cells. Quantification of dots per cell in 6
Rev-CTIF (n = 32 cells), Rev-CTIF(1-305) (n = 44 cells) and Rev-CTIF(306-598) (n = 43 cells) 7 are presented (****P < 0.0001, NS; non-significant, Mann-Whitney test). 8 C) HeLa cells transfected with pNL4.3 together with pCDNA3-Flag-CTIF, pCDNA-Flag-9 CTIF(1-305) or pCDNA-Flag-CTIF(306-598) were subjected to ISH-PLA as described (Ref) . Flag-CTIF together with 0.3 µg of pNL4.3R (HIV-1) or pROD10R (HIV-2) and Renilla activity 31 was determined at 24 hpt. Results were normalized to the control (arbitrary set to 100%) and 1 correspond to the mean +/-SD of three independent experiments (**P < 0.01, ***P < 0.001; t-2 test). In parallel, cells extracts were used to detect Flag-CTIF by Western blot for expression 3 control. Actin were used as a loading control. 4 B) HEK293T cells were transfected with 1.5 µg of pcDNA-d2EGFP (Control) or pcDNA3-Flag-5 CTIF together with 0.5 µg of pNCAC. Cells extract were prepared 24 hpt and subjected to 6
Western blot to detect CAp30 of MLV, Flag-CTIF. GAPDH was used as a loading control. 7 C) HEK293T cells were transfected with 1 µg of pcDNA-d2EGFP (Control) or pcDNA3-Flag-8 CTIF and 6 h post-transfection the cells were infected with hRSV MOI: 1. Cells extracts were 9 prepared at 24 hpi and subjected to Western blot to detect the viral F protein and Flag-CTIF. 10 GAPDH was used as a loading control. 
